Profile data is unavailable for this security.
About the company
Bafna Pharmaceuticals Limited is an India-based company, which is engaged in the manufacture of drugs and medicines and selling a reputed brand namely RARICAP. The Company caters to both domestic and international market. It operates in generic pharmaceutical segment. The Company manufactures 336 licensed pharmaceutical formulations and have globally registered 78 of its products. It supplies its products to the United Kingdom, Europe, and Australian markets. The Company's Grantlyon facility has the capability to supply both small-scale clinical trial quantities and commercial-scale requirements. The Company’s subsidiary is Bafna Lifestyles Remedies Limited.
- Revenue in INR (TTM)1.44bn
- Net income in INR2.73m
- Incorporated1995
- Employees618.00
- LocationBafna Pharmaceuticals LtdBafna Towers, 299, Thambu Chetty streetCHENNAI 600001IndiaIND
- Phone+91 4 442677555
- Fax+91 4 442677599
- Websitehttp://www.bafnapharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vaidya Sane Ayurved Laboratories Ltd | 993.31m | 19.80m | 1.49bn | 636.00 | 84.90 | 2.67 | 28.94 | 1.50 | 1.66 | 1.66 | 78.54 | 52.89 | 1.58 | 6.83 | 15.11 | 1,561,813.00 | 3.16 | 4.83 | 4.02 | 7.49 | 74.12 | 70.91 | 2.00 | 2.53 | 2.11 | 5.49 | 0.0293 | -- | 0.1638 | 9.71 | -59.02 | 31.91 | 4.43 | -- |
Sotac Pharmaceuticals Ltd | 1.10bn | 37.21m | 1.52bn | 89.00 | 40.75 | -- | 21.34 | 1.38 | 3.37 | 3.37 | 99.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 21.53 | -- | 3.38 | -- | -- | 2.75 | -- | -- | 79.07 | -- | -20.38 | -- | -- | -- |
Krebs Biochemicals And Industries Ltd | 527.29m | -195.67m | 1.73bn | 191.00 | -- | -- | -- | 3.28 | -9.08 | -9.08 | 24.47 | -- | -- | -- | -- | 2,760,691.00 | -- | -17.87 | -- | -27.01 | 85.82 | 15.68 | -37.11 | -58.62 | -- | -3.08 | -- | -- | -3.29 | 1.09 | 20.10 | -- | 16.76 | -- |
Aarey Drugs and Pharmaceuticals Ltd | 4.72bn | 65.28m | 1.77bn | 0.00 | 24.80 | -- | 21.38 | 0.3751 | 2.51 | 2.51 | 179.80 | -- | -- | -- | -- | -- | -- | 2.30 | -- | 5.01 | 2.99 | 3.58 | 1.38 | 1.40 | -- | 0.5731 | -- | -- | -5.57 | 2.21 | 24.20 | -6.46 | -10.07 | -- |
Quest Laboratories Ltd | 825.63m | 100.94m | 1.83bn | 74.00 | 16.68 | 4.65 | 17.16 | 2.22 | 6.69 | 6.69 | 58.30 | 23.99 | -- | -- | -- | 11,157,140.00 | -- | -- | -- | -- | 36.72 | -- | 12.23 | -- | 0.8904 | 33.56 | 0.1507 | -- | 33.94 | -- | 100.73 | -- | -- | -- |
Bafna Pharmaceuticals Ltd | 1.44bn | 2.73m | 1.87bn | 618.00 | 683.72 | -- | 34.09 | 1.30 | 0.1159 | 0.1159 | 60.96 | -- | -- | -- | -- | 2,326,939.00 | -- | 5.45 | -- | 8.23 | 26.69 | 35.05 | 0.19 | 5.97 | -- | 0.3419 | -- | -- | 32.15 | 28.45 | -35.19 | -- | 116.51 | -- |
Mangalam Drugs and Organics Ltd | 3.58bn | 31.71m | 1.96bn | 432.00 | 61.83 | -- | 10.72 | 0.5474 | 2.00 | 2.00 | 225.39 | -- | -- | -- | -- | 8,279,234.00 | -- | 3.28 | -- | 5.89 | 38.76 | 27.83 | 0.8866 | 2.59 | -- | 0.9785 | -- | -- | -0.9827 | 10.12 | -812.51 | -- | 13.92 | -- |
Zenith Drugs Ltd | 1.32bn | 95.93m | 2.00bn | 126.00 | 20.82 | 3.21 | 18.24 | 1.52 | 5.59 | 5.59 | 76.75 | 36.31 | -- | -- | -- | 10,446,010.00 | -- | -- | -- | -- | 35.03 | -- | 7.33 | -- | 1.37 | 7.08 | 0.2833 | -- | 14.93 | -- | 96.54 | -- | -- | -- |
Bal Pharma Ltd | 3.43bn | 75.67m | 2.09bn | -- | 27.30 | -- | 11.88 | 0.6086 | 4.81 | 4.81 | 217.63 | -- | -- | -- | -- | -- | -- | 0.5654 | -- | 1.57 | 44.05 | 43.04 | 2.22 | 0.5638 | -- | 1.36 | -- | 79.39 | 11.51 | 8.56 | 187.44 | 14.31 | 5.02 | 3.71 |
Data as of Oct 11 2024. Currency figures normalised to Bafna Pharmaceuticals Ltd's reporting currency: Indian Rupee INR